Establishment and validation of a predictive model of recurrence in primary hepatocellular carcinoma after resection

被引:4
|
作者
Xu, Yang [1 ]
Han, Huimin [1 ]
Cao, Wei [1 ]
Fu, Hongxing [1 ]
Liu, Yang [1 ]
Yan, Li [2 ]
Qin, Tingting [1 ]
机构
[1] Wuhan Third Hosp, Dept Integrated Tradit Chinese & Western Med, 241 Pengliuyang Rd, Wuhan 430060, Peoples R China
[2] Wuhan Third Hosp, Dept Tradit Chinese Med, 241 Pengliuyang Rd, Wuhan 430060, Peoples R China
关键词
Primary hepatocellular carcinoma; operation; recurrence; prediction model; CANCER; ASCITES;
D O I
10.21037/jgo-22-1303
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: In recent years, nomogram prediction models have been widely used to evaluate the prognosis of various diseases. However, studies in primary hepatocellular carcinoma (HCC) are limited. This study sought to explore the risk factors of recurrence of patients with primary HCC after surgical resection and establish a nomogram prediction model. Methods: The data of 424 patients with primary HCC who had been admitted to the Wuhan Third Hospital were retrospectively collected. The patients were followed-up for 5 years after surgery. The patients were divided into the recurrence group (n=189) and control group (n=235) according to whether the cancer recurred after surgery. The differences in the clinical characteristics between the two groups were analyzed. The risk factors of recurrence after surgical resection of primary HCC were also analyzed, and a prediction model was then established using R4.0.3 statistical software. Results: There were significant statistical differences between the two groups in terms of the tumor size, systemic immune-inflammation (SII) index, the number of lesions, tumor differentiation degree, ascites, vascular invasion, and portal vein tumor thrombus (P<0.05). The multivariate regression analysis showed that multiple foci, poorly differentiated tumors, ascites, vascular invasion, and portal vein tumor thrombus were risk factors for the recurrence of primary HCC in patients after surgical resection (P<0.05). The data set was randomly divided into a training set and verification set. The sample size of the training set was 297, and the sample size of the verification set was 127. The area under the receiver operating characteristic (ROC) curve of the training set was 0.866 [95% confidence interval (CI): 0.824-0.907], and the area under the ROC curve of the validation set was 0.812 (95% CI: 0.734-0.890). The Hosmer-Lemeshow Goodness-of-Fit Test was used to test the model with the validation set (chi(2)=11.243, P=0.188), which indicated that the model had high value in predicting the recurrence of primary HCC after surgical resection. Conclusions: This model had high value in predicting the recurrence of primary HCC in patients after surgical resection. This model could assist clinicians to assess the prognosis of patients. Intensive treatment for high-risk patients might improve the prognosis of patients.
引用
收藏
页码:278 / 286
页数:9
相关论文
共 50 条
  • [1] Establishment and validation of a prognostic model for hepatocellular carcinoma after radical liver resection
    Xu, Yan
    Zhang, Jianxian
    Bai, Yuhuan
    Jing, Changchun
    Zhang, Zhifeng
    Sun, Xiaoyu
    Yang, Dong
    Duan, Zhijun
    JOURNAL OF BUON, 2019, 24 (04): : 1420 - 1428
  • [2] A nomogram for predicting recurrence of primary hepatocellular carcinoma after resection
    Dai, Yunlong
    Feng, Qingbo
    Huang, Jiwei
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (04) : 1900 - 1901
  • [3] Recurrence after resection of hepatocellular carcinoma
    J-MRegimbeau
    J.Belghiti
    Hepatobiliary & Pancreatic Diseases International, 2002, (03) : 401 - 405
  • [4] Validation of an alpha-fetoprotein model to predict recurrence after liver resection for hepatocellular carcinoma
    Li, Wei-Feng
    Yen, Yi-Hao
    Liu, Yueh-Wei
    Wang, Chih-Chi
    Yong, Chee-Chien
    Lin, Chih-Che
    Cheng, Yu-Fan
    Wang, Jing-Houng
    UPDATES IN SURGERY, 2022, 74 (04) : 1345 - 1352
  • [5] Development and Validation of a Machine Learning Prognostic Model for Hepatocellular Carcinoma Recurrence After Surgical Resection
    Huang, Yao
    Chen, Hengkai
    Zeng, Yongyi
    Liu, Zhiqiang
    Ma, Handong
    Liu, Jingfeng
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [6] Validation of an alpha-fetoprotein model to predict recurrence after liver resection for hepatocellular carcinoma
    Wei-Feng Li
    Yi-Hao Yen
    Yueh-Wei Liu
    Chih-Chi Wang
    Chee-Chien Yong
    Chih-Che Lin
    Yu-Fan Cheng
    Jing-Houng Wang
    Updates in Surgery, 2022, 74 : 1345 - 1352
  • [7] Establishment, validation and evaluation of predictive model for early relapse after R0 resection in hepatocellular carcinoma patients with microvascular invasion
    Zhang, Kai
    Tao, Changcheng
    Siqin, Tana
    Wu, Jianxiong
    Rong, Weiqi
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [8] Establishment, validation and evaluation of predictive model for early relapse after R0 resection in hepatocellular carcinoma patients with microvascular invasion
    Kai Zhang
    Changcheng Tao
    Tana Siqin
    Jianxiong Wu
    Weiqi Rong
    Journal of Translational Medicine, 19
  • [9] Metabolic risk factors are predictive of hepatocellular carcinoma recurrence after surgical resection
    Thilakanathan, C.
    Goodwin, T.
    Kim, C.
    Akon, A. C.
    Jebeili, H.
    Chu, F.
    Smith, M.
    Behary, J.
    Majeed, A.
    Kemp, W.
    Roberts, S. K.
    Zekry, A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 49 - 50
  • [10] METABOLIC RISK FACTORS ARE PREDICTIVE OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER SURGICAL RESECTION
    Thilakanathan, Cynthuja
    Goodwin, Thomas
    Kim, Christy
    Akon, Anna Camille
    Jebeili, Hazem
    Chu, Francis
    Behary, Jason
    Majeed, Ammar
    Kemp, William W.
    Roberts, Stuart K.
    Zekry, Amany
    HEPATOLOGY, 2021, 74 : 658A - 658A